Vraylar

Vraylar (cariprazine) is a prescription medication used to treat Bipolar disorder, schizophrenia, depression (add-on). An oral antipsychotic for bipolar I disorder and schizophrenia, also used as an add-on treatment for major depression.

Partially modulates dopamine D2/D3 and serotonin receptors to help balance mood and thinking.

Commonly reported side effects of Vraylar include Movement disorders, Drowsiness, Restlessness, Weight changes, and Increased mortality in dementia patients. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Yes. Vraylar carries an FDA Boxed Warning — the agency's most serious safety warning. Read the full prescribing information and talk to your doctor about the risks before starting or changing treatment.

The active ingredient in Vraylar is cariprazine, which belongs to a class of medicines known as Atypical Antipsychotic.

Vraylar is manufactured by AbbVie. It was first approved in 2015.

You may be able to lower the cost of Vraylar by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.